Marinus Pharmaceuticals reported $37K in Ordinary Share Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Adamas Pharmaceuticals ADMS:US 50K 0
ALKERMES ALKS:US $ 1.65M 0.01M
Amgen AMGN:US $ 31877M 71M
Aptinyx Inc APTX:US $ 677K 8K
Arena Pharmaceuticals ARNA:US $ 0.01M 0M
Biogen BIIB:US $ 0.1M 0M
Eisai 4523:JP Y 44986M 0M
Esperion Therapeutics ESPR:US $ 26K 0
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
Intra Cellular Therapies ITCI:US $ 0.01M 0M
Marinus Pharmaceuticals MRNS:US $ 0.04M 0M
Minerva Neurosciences NERV:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Supernus Pharmaceuticals SUPN:US $ 0.05M 0M
Vertex Pharmaceuticals VRTX:US $ 2.59M 0M
YTE INCY:US $ 0.22M 0M
Zogenix ZGNX:US $ 0M 0M